Security key
98943L107
Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL)
CUSIP: 98943L107
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Common Stock,$0.001 par value per share
- Shares outstanding
- 72,096,078
- Total 13F shares
- 80,197,042
- Share change
- -2,241,574
- Total reported value
- $1,608,751,464
- Put/Call ratio
- 20%
- Price per share
- $20.06
- Number of holders
- 136
- Value change
- -$51,643,382
- Number of buys
- 67
- Number of sells
- 51
Report period
Q3 2023
Institutions
136
Top holders
10
ZNTL full security history
Newer quarter: Q4 2023
Previous quarter: Q2 2023
Zentalis Pharmaceuticals, Inc. SEC filings
Zentalis Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98943L107
Recent filing periods:
Top shareholders of ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Matrix Capital Management Company, LP |
13F
|
Company |
19%
|
13,959,973
|
$393,810,838 | — | 30 Jun 2023 | |
| FMR LLC |
13F
|
Company |
15%
|
10,576,572
|
$298,365,097 | — | 30 Jun 2023 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
9.5%
|
6,877,803
|
$194,022,823 | — | 30 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.8%
|
4,929,173
|
$139,051,970 | — | 30 Jun 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.5%
|
3,950,804
|
$111,452,179 | — | 30 Jun 2023 | |
| STATE STREET CORP |
13F
|
Company |
4.4%
|
3,152,914
|
$88,943,704 | — | 30 Jun 2023 | |
| Capital International Investors |
13F
|
Company |
4.3%
|
3,127,758
|
$88,234,053 | — | 30 Jun 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
3.7%
|
2,684,352
|
$75,726,000 | — | 30 Jun 2023 | |
| Avidity Partners Management LP |
13F
|
Company |
3.2%
|
2,334,000
|
$65,842,140 | — | 30 Jun 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
3%
|
2,129,296
|
$60,067,440 | — | 30 Jun 2023 | |
| Decheng Capital Management III (Cayman), LLC |
13F
|
Company |
2.9%
|
2,099,583
|
$59,229,236 | — | 30 Jun 2023 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
2.8%
|
2,018,234
|
$56,934,381 | — | 30 Jun 2023 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2.8%
|
1,999,354
|
$56,402,000 | — | 30 Jun 2023 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
2.6%
|
1,908,444
|
$53,837,205 | — | 30 Jun 2023 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.8%
|
1,321,435
|
$37,277,681 | — | 30 Jun 2023 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
1.5%
|
1,111,150
|
$31,345,542 | — | 30 Jun 2023 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.5%
|
1,095,000
|
$30,889,950 | — | 30 Jun 2023 | |
| Woodline Partners LP |
13F
|
Company |
1.5%
|
1,094,974
|
$30,889,217 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
1,067,601
|
$30,117,033 | — | 30 Jun 2023 | |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD |
13F
|
Company |
1.3%
|
961,486
|
$27,123,520 | — | 30 Jun 2023 | |
| Anthony Y. Sun |
3/4/5
|
President & CEO, Director |
—
class O/S missing
|
2,592,141
|
$26,672,095 | — | 04 Apr 2022 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
1.1%
|
828,005
|
$23,358,021 | — | 30 Jun 2023 | |
| First Light Asset Management, LLC |
13F
|
Company |
1.1%
|
757,835
|
$21,378,525 | — | 30 Jun 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1%
|
733,577
|
$20,694,208 | — | 30 Jun 2023 | |
| Capital World Investors |
13F
|
Company |
0.95%
|
683,000
|
$19,267,430 | — | 30 Jun 2023 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.77%
|
555,000
|
$15,656,550 | — | 30 Jun 2023 | |
| Iris Roth |
3/4/5
|
Chief Operating Officer |
—
mixed-class rows
|
350,000
mixed-class rows
|
$14,760,704 | — | 01 Mar 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.72%
|
516,045
|
$14,557,629 | — | 30 Jun 2023 | |
| Verition Fund Management LLC |
13F
|
Company |
0.7%
|
507,020
|
$14,303,034 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.7%
|
502,875
|
$14,186,102 | — | 30 Jun 2023 | |
| 5AM Venture Management, LLC |
13F
|
Company |
0.68%
|
490,000
|
$13,822,900 | — | 30 Jun 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.66%
|
478,803
|
$13,507,033 | — | 30 Jun 2023 | |
| Boxer Capital, LLC |
13F
|
Company |
0.62%
|
450,000
|
$12,695,000 | — | 30 Jun 2023 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.62%
|
450,000
|
$12,694,500 | — | 30 Jun 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.58%
|
419,226
|
$11,826,366 | — | 30 Jun 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.56%
|
405,845
|
$11,448,887 | — | 30 Jun 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.52%
|
373,904
|
$10,547,765 | — | 30 Jun 2023 | |
| Deep Track Capital, LP |
13F
|
Company |
0.42%
|
300,300
|
$8,471,463 | — | 30 Jun 2023 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.42%
|
300,000
|
$8,463,000 | — | 30 Jun 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.37%
|
265,484
|
$7,489,304 | — | 30 Jun 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.35%
|
250,957
|
$7,079,497 | — | 30 Jun 2023 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.32%
|
234,000
|
$6,601,140 | — | 30 Jun 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.29%
|
212,415
|
$5,992,227 | — | 30 Jun 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.29%
|
210,437
|
$5,936,000 | — | 30 Jun 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.28%
|
202,679
|
$5,717,575 | — | 30 Jun 2023 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.27%
|
194,933
|
$5,499,060 | — | 30 Jun 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.26%
|
188,320
|
$5,312,507 | — | 30 Jun 2023 | |
| Mayo Clinic |
13F
|
Company |
0.26%
|
187,143
|
$5,279,304 | — | 30 Jun 2023 | |
| NORGES BANK |
13F
|
Company |
0.23%
|
167,742
|
$4,732,002 | — | 30 Jun 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.23%
|
164,537
|
$4,641,589 | — | 30 Jun 2023 |
Institutional Holders of Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL) as of Q3 2023
As of 30 Sep 2023,
Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL) was held by
136 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
80,197,042 shares.
The largest 10 holders included
Matrix Capital Management Company, LP, FMR LLC, EVENTIDE ASSET MANAGEMENT, LLC, VANGUARD GROUP INC, BlackRock Inc., Capital International Investors, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, CITADEL ADVISORS LLC, and Avidity Partners Management LP.
This page lists
136
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
131
Q3 2023 holders
136
Holder diff
5
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.